Novonesis
403
DKK
-0.76 %
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
-0.76%
-1.15%
-3.33%
-14.46%
-7.46%
+10.23%
-22.2%
+25.16%
+989.19%
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Read moreMarket cap
188.72B DKK
Turnover
161.25M DKK
Revenue
17.9B
EBIT %
22.21 %
P/E
36.9
Dividend yield-%
1.54 %
Financial calendar
26/2
2025
Annual report '24
3/4
2025
General meeting '25
13/8
2025
Interim report Q2'25
ShowingAll content types
Change to Novonesis’ Board of Directors
Major shareholder announcement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools